Become a Member | Print Page | Contact Us | Report Abuse | Sign In
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

News
Wednesday, June 3, 2020   (0 Comments - view/add)
The Call for Nominations has been extended until, Sunday, June 14, 2020, at midnight. »
The Call for Nominations has been extended until, Sunday, June  14, 2020, at midnight.   ITOG  is...
Wednesday, June 3, 2020   (0 Comments - view/add)
The Call for Nominations has been extended until, Sunday, June 14, 2020, at midnight. »
The Call for Nominations has been extended until, Sunday, June  14, 2020, at midnight.   ITOG  is...
Thursday, May 21, 2020   (0 Comments - view/add)
ITOG Nominations are now Open »
  Nominations now open for ITOG Board of Directors Call for nominations will open on  Friday, May 15, 2...
Wednesday, May 20, 2020   (1 Comment - view/add)
ITOG Quarterly Newsletter June 2020 »
ITOG Quarterly Newsletter June 2020  j...
Friday, May 15, 2020   (0 Comments - view/add)
ACCRU-ITOG-1504 Achieves Accrual Goal »
  Congratulations  to  Principal Investigator:  Bryan Haugen  at  The  Univers...

Annual Meeting
Saturday, October 19, 2019   (0 Comments - view/add)
2019 ITOG Annual Meeting: One of the very best »
The 12th Annual Meeting of the International Thyroid Oncology Group was held in early May in New York City, New York, and...

Philanthropy
Saturday, October 19, 2019   (0 Comments - view/add)
Massachusetts General Hospital Honors Elizabeth and Michael Ruane »
Elizabeth and Michael Ruane have been extremely generous benefactors, not only to ITOG, but also to the medical community...
Saturday, October 19, 2019   (0 Comments - view/add)
TA Realty Fundraiser Raises over $100,000 »
TA Associates Realty is one of the leading investors in commercial real estate in the United States. Michael Ruane, a foun...

Connect With Us

International Thyroid Oncology Group

5166 Commercial Drive

Yorkville, New York 13495

614-293-9779

 

Our mission
To catalyze a cure for the most challenging thyroid cancers through the collaborative efforts of our unique multidisciplinary team of leading physicians, scientists, and advocates to design, coordinate, and prioritize state-of-the-art clinical trials and correlative science.